Two recent papers report the first-in-human clinical trials investigating the efficacy and safety of faecal microbiota transplantation for metastatic melanoma that is refractory to cancer immunotherapy.
Overcoming hurdles in cancer immunotherapy
Review badges
0 pre-pub reviews
0 post-pub reviews